Table 2 Clinico-pathological characteristics of patients with early-stage OCCC who completed 1–3 or ≥ 4 cycles of platinum-based chemotherapy
Parameters | Chemotherapy cycle:1-3cycles (n = 20) (n,%) | Chemotherapy cycle: ≥4 cycles (n = 82) (n,%) | P |
|---|---|---|---|
Age (yr) | |||
≤ 52 | 12 (60.0) | 35 (42.7) | 0.164 |
> 52 | 8 (40.0) | 47 (57.3) | |
Menopause | |||
Premenopause | 11 (55.0) | 24 (29.3) | 0.030 |
Postmenopause | 9 (45.0) | 58 (70.7) | |
Family history of malignancy | |||
No | 15 (75.0) | 69 (84.1) | 0.525 |
Yes | 5 (25.0) | 12 (15.9) | |
Tumor size | |||
<10cm | 7 (35.0) | 26 (31.7) | 0.778 |
≥10cm | 13 (65.0) | 56 (68.3) | |
CA125 (u/ml) | |||
≤ 35 | 7 (35.0) | 41 (50.0) | 0.228 |
> 35 | 13 (65.0) | 41 (50.0) | |
Ascites positivity | |||
No | 15 (75.0) | 72 (87.8) | 0.272 |
Yes | 5 (25.0) | 10 (12.2) | |
Endometriosis | |||
No | 7 (35.0) | 26 (31.7) | 0.778 |
Yes | 13 (65.0) | 56 (68.3) | |
Surgical approach | |||
Laparotomy | 15 (75.0) | 76 (92.7) | 0.060 |
Laparoscopy | 5 (25.0) | 6 (7.3) | |
FIGO | 0.182 | ||
IA | 9 (45.0) | 37 (45.1) | |
IC | 6 (30.0) | 37 (45.1) | |
IIA | 5 (25.0) | 9 (9.8) |